comparemela.com

Latest Breaking News On - New swan multitech - Page 1 : comparemela.com

Medi Assist Healthcare IPO allotment likely today: Check status, GMP, listing date and other details

Medi Assist Healthcare will finalize share allotment to investors today evening. Investors will be allocated shares on a lottery basis. Investors can check allotment status on BSE or registrar website. IPO was subscribed 16 times, commanding Rs 25 premium in unlisted market.

capital expenditure: New Swan Multitech sees 90% premium listing over IPO price

Shares of New Swan Multitech listed with a premium of 90% on the BSE SME platform. The stock debuted at Rs 125.4, compared with an offer price of Rs 66. The company s shares commanded a GMP of Rs 56 in the unlisted market. The IPO was entirely a fresh equity issue of 50.16 and through the issue, the company plans to raise Rs 33.11 crore.

Maxposure IPO allotment soon: Check status, GMP, listing date and other details

Maxposure IPO Allotment: The SME IPO Maxposure received the highest subscription so far in 2024 at nearly 905 times at close. Investors are eagerly awaiting the IPO allotment process for Maxposure. The IPO is a fresh equity issue of 61.4 lakh shares to raise Rs 20.26 crore. The net proceeds will be used for funding expenses, working capital, debt repayment, and general corporate purposes.

Lawsikho SME IPO: Check price band, GMP, financials, risks and listing date

New Swan Multitech IPO allotment to be finalised today Check status, GMP, listing date and other details

The share allotment for the SME IPO of New Swan Multitech will be finalised today. Investors will get shares on a lottery basis. They can check the allotment status through the BSE or by visiting the official website of the registrar. The SME IPO of New Swan Multitech was subscribed 380 times at close. The category reserved for retail investors was subscribed 388 times and the NII portion was booked 730 times. The shares will likely get listed on January 18.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.